📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology (2019)

First Author: Barnes T

Attributed to: MICA: Targeting neuro-inflammation in Schizophrenia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/0269881119889296

PubMed Identifier: 31829775

Publication URI: http://europepmc.org/abstract/MED/31829775

Type: Journal Article/Review

Parent Publication: Journal of Psychopharmacology

Issue: 1

ISSN: 0269-8811